![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Astellas, UCB Introduce Rheumatoid Arthritis Therapy in Japan
Astellas, UCB Introduce Rheumatoid Arthritis Therapy in Japan
March 4, 2013
Astellas Pharma and UCB have introduced Cimzia rheumatoid arthritis therapy in Japan. The PEGylated Fc-free anti-TNF medication is indicated for adult rheumatoid arthritis patients who showed poor response to conservative treatment.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
21Oct